مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,079
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

HEPATITIS B IN PATIENTS WITH END-STAGE RENAL DISEASE UNDERGOING MAINTENANCE HEMODIALYSIS

Pages

  450-459

Abstract

 Despite all prevention methods, HEPATITIS B virus (HBV), which can cause acute and chronic hepatitis, cirrhosis and liver cancer, still has remained endemic in many areas and more than 350 million people are chronic carriers of this virus in the world. The incidence of HEPATITIS B infection has significantly decreased among the patients with end stage renal disease during the past few decades due to factors such as blood screening for HBsAg and anti-HBc, reducing the need for blood transfusion after the advent of erythropoietin, HEPATITIS B vaccination and the implementation of infection control measures in HEMODIALYSIS units. It seems that HBsAg test is sufficient for the diagnosis of HBV infection in most end stage renal disease (ESRD) patients. However since the biochemical tests often cannot be reliable to indicate the status of liver pathology, the liver biopsy is the best method to ascertain the activity of hepatitis and the degree of cirrhosis. It is often recommended when antiviral treatment is being considered and before kidney transplantation for assesses the activity of HBV-related liver disease. According to the side effects of interferon-alfa among dialysis patients, nucleoside analogs are better choices for the treatment of HEPATITIS B among these patients. Finally it should be noted that Entecavir is the recommended first-line oral medication for HEPATITIS B among these patients.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    BELADI MOUSAVI, SEYED SEYF ELAH, SHAHBAZIAN, HESHMATOLLAH, FARAMARZI, MOHAMMAD, KHODADADI, SAMANEH, & NASRI, HAMID. (2016). HEPATITIS B IN PATIENTS WITH END-STAGE RENAL DISEASE UNDERGOING MAINTENANCE HEMODIALYSIS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 34(380), 450-459. SID. https://sid.ir/paper/50268/en

    Vancouver: Copy

    BELADI MOUSAVI SEYED SEYF ELAH, SHAHBAZIAN HESHMATOLLAH, FARAMARZI MOHAMMAD, KHODADADI SAMANEH, NASRI HAMID. HEPATITIS B IN PATIENTS WITH END-STAGE RENAL DISEASE UNDERGOING MAINTENANCE HEMODIALYSIS. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2016;34(380):450-459. Available from: https://sid.ir/paper/50268/en

    IEEE: Copy

    SEYED SEYF ELAH BELADI MOUSAVI, HESHMATOLLAH SHAHBAZIAN, MOHAMMAD FARAMARZI, SAMANEH KHODADADI, and HAMID NASRI, “HEPATITIS B IN PATIENTS WITH END-STAGE RENAL DISEASE UNDERGOING MAINTENANCE HEMODIALYSIS,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 34, no. 380, pp. 450–459, 2016, [Online]. Available: https://sid.ir/paper/50268/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button